The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorChinese PLA General Hospital

About this trial

1. To evaluate the clinical outcomes of ultrasound-guided thermal ablation and thyroid surgery for the treatment of papillary thyroid carcinoma; 2. To develop and validate a artificial intelligence model to predict the outcomes of ultrasound-guided thermal ablation in the treatment of papillary thyroid carcinoma;

Eligibility criteria

Qualifiers

patients age between 18 and 80 year old, both sex

papillary thyroid carcinoma confirmed by core-needle biopsy or fine-needle aspiration

the largest diameter ≤2.0 cm

no clinical or imaging evidences of extrathyroidal extension, lymph node metastasis and distant metastasis on ultrasound, nech and chest CT

Disqualifiers

patients with convincing evidence of aggressive papillary thyroid carcinoma or other type of thyroid cancer by biopsy

history of neck radiation

history of thyroid surgery

coagulation disorder

Trial design

Treatments tested in this trial

  • thyroid surgery
  • ultrasound-guided thermal ablation

Treatment groups

3,772 Participants
are divided into 2 treatment groups

Sponsors and collaborators